US Patent Issued to COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES on Oct. 14 for "Hybrid htiRNA/nanoparticle complex and use thereof for treating a disease of the digestive system" (French Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,999, issued on Oct. 14, was assigned to COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (Paris).

"Hybrid htiRNA/nanoparticle complex and use thereof for treating a disease of the digestive system" was invented by Fabrice Navarro Y Garcia (Grenoble, France), Dorothee Jary (Grenoble, France) and Adrien Nougarede (Grenoble, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "A hybrid DNA/RNA molecule, or a complex thereof with at least one nanoparticle, may be used for the prevention or treatment of a disease, in particular a disease of the digestive system."

The patent was filed on July 15, 2020, under Application No. 17/627,040.

*F...